View Older Stories

Feb 24, 2026 04:01PM Cytokinetics (CYTK) Tops Q4 EPS by 6c

Feb 17, 2026 07:38AM Cytokinetics gets European approval for heart drug MYQORZO

Feb 4, 2026 06:48AM B.Riley Reiterates Buy Rating on Cytokinetics (CYTK)

Jan 28, 2026 03:29AM Barclays Assumes Cytokinetics (CYTK) at Overweight

Jan 27, 2026 09:44AM Truist: 'We remain buyers of CYTK following KOL feedback'

Jan 27, 2026 07:32AM Cytokinetics launches MYQORZO for hypertrophic cardiomyopathy in US

Jan 9, 2026 07:52AM Cytokinetics (CYTK) PT Raised to $90 at Jefferies

Dec 23, 2025 09:25AM Cytokinetics (CYTK) PT Raised to $84 at Truist Securities

Dec 22, 2025 07:25AM Cytokinetics (CYTK) PT Raised to $84 at Needham

Dec 22, 2025 07:09AM Cytokinetics (CYTK) PT Raised to $136 at H.C. Wainwright

Dec 22, 2025 06:44AM Cytokinetics (CYTK) PT Raised to $95 at RBC Capital

Dec 22, 2025 06:40AM Cytokinetics (CYTK) PT Raised to $88 at Citizens

Dec 21, 2025 08:00PM Here's the list of top biotech stocks to own for 2026

Dec 19, 2025 01:52PM Cytokinetics (CYTK) halted, news pending

Dec 18, 2025 06:43AM Goldman Sachs Upgrades Cytokinetics (CYTK) to Buy

Dec 17, 2025 07:30AM Cytokinetics receives China approval for heart drug MYQORZO

Dec 12, 2025 08:43AM Cytokinetics receives positive CHMP opinion for heart drug MYQORZO

Dec 8, 2025 07:32AM Piper Sandler on Biotechnology: 'What Commercial Names to Own in 2026?'

Dec 1, 2025 09:24AM Cytokinetics (CYTK) PT Raised to $61 at UBS

Nov 11, 2025 08:38AM Cytokinetics (CYTK) PT Raised at RBC Capital into Aficamten 2026 Launch

Nov 10, 2025 07:31AM Cytokinetics presents additional MAPLE-HCM trial data at medical conferences

Nov 5, 2025 04:04PM Cytokinetics (CYTK) Misses Q3 EPS by 98c

Oct 21, 2025 08:47AM Cantor Fitzgerald Reiterates Cytokinetics (CYTK) at Overweight Post Model Update

Oct 6, 2025 02:25AM Cytokinetics (CYTK) PT Raised to $82 at Barclays

Oct 1, 2025 07:14AM Cytokinetics (CYTK) PT Lowered to $95 at Stifel

Sep 30, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)

Sep 29, 2025 02:58PM Cytokinetics (CYTK) October 40 calls and January 55 calls active

Sep 29, 2025 07:07AM Stifel Reiterates Buy Rating on Cytokinetics (CYTK)

Sep 23, 2025 04:19AM Citizens JMP Reiterates Market Outperform Rating on Rapport Therapeutics (RAPP)

Sep 23, 2025 04:18AM Citizens JMP Reiterates Market Outperform Rating on Abivax (ABVX)

Sep 22, 2025 06:06AM H.C. Wainwright Reiterates $120 PT Cytokinetics (CYTK), Top Pick

Sep 16, 2025 04:12PM Cytokinetics meets with FDA on aficamten drug application

Sep 11, 2025 08:18AM RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'

Sep 3, 2025 10:39AM Jefferies on Cytokinetics (CYTK): 'we await some indication that these initiatives will deliver the intended results'

Sep 3, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)

Sep 2, 2025 10:25AM Cytokinetics (CYTK) PT Raised to $96 at Stifel

Sep 2, 2025 09:35AM Truist: 'We Remain Buyers of Cytokinetics (CYTK)'

Sep 2, 2025 07:20AM Cytokinetics presents aficamten data at cardiology congress

Aug 7, 2025 04:04PM Cytokinetics (CYTK) Tops Q2 EPS by 30c, provides guidance

Jul 29, 2025 04:26PM Raymond James Assumes, Downgrades Cytokinetics (CYTK) to Market Perform

Jul 22, 2025 05:00AM Citi Adjusts North American Focus List

Jun 9, 2025 05:09AM Cytokinetics (CYTK) PT Lowered to $53 at JPMorgan

May 29, 2025 06:36AM Cytokinetics (CYTK) PT Lowered to $84 at Mizuho

May 27, 2025 09:51AM Stifel Reiterates Buy Rating on Cytokinetics (CYTK)

May 13, 2025 08:26AM Stifel on Cytokinetics (CYTK): 'we remain confident in a best-in-class opportunity for aficamten'

May 13, 2025 07:30AM Cytokinetics (CYTK) Announces Positive Topline Results From MAPLE-HCM

May 7, 2025 05:28AM Cytokinetics (CYTK) PT Lowered to $60 at Evercore ISI

May 7, 2025 05:05AM Cytokinetics (CYTK) PT Lowered to $80 at Citi

May 7, 2025 04:13AM Citizens JMP Reiterates Market Outperform Rating on Cytokinetics (CYTK)

May 6, 2025 04:04PM Cytokinetics (CYTK) Tops Q1 EPS by 1c

View Older Stories